The AI boom is visible from orbit. Satellite photos of New Carlisle, Indiana, show greenish splotches of farmland transformed ...
An Indian web developer demonstrated how Perplexity AI's Comet browser could autonomously breeze through an entire Coursera course on AI ethics in mere seconds, prompting a swift and stern rebuke from ...
Microsoft has withdrawn its proposal for a data center in Caledonia. The decision was made in response to opposition from local residents and officials. The company remains committed to investing in ...
SALINE TWP., MI — Despite local officials’ opposition, a controversial plan to build a 2.2-million-square-foot data center on farmland may still happen. A rural community in southeast Washtenaw County ...
A.R.E. Taylor does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
The new Gemini Robotics 1.5 models enable robots to carry out multistep tasks and even learn from each other. The new Gemini Robotics 1.5 models enable robots to carry out multistep tasks and even ...
Businesses today rely heavily on data to make faster decisions, optimize operations, and unlock revenue streams. Yet most enterprises are drowning in fragmented data infrastructure, with engineering ...
Harsh Goenka highlights the World Economic Forum's 2025 Future of Jobs Report, projecting significant growth in roles like Big Data Specialists, FinTech Engineers, and AI & Machine Learning ...
PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.
Preliminary annual revisions could add to political pressure on the agency that produces the data. Preliminary annual revisions by the Bureau of Labor Statistics show that 911,000 fewer jobs were ...
CG Oncology (CGON) Is Up 23.3% After 24-Month Complete Response Data in Phase 3 Bladder Cancer Study
CG Oncology recently released updated data from its Phase 3 BOND-003 Cohort C study, which showed a 41.8% 24-month complete response rate for cretostimogene monotherapy in heavily pretreated patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results